Welcome to our dedicated page for HALLIBURTON CO SEC filings (Ticker: HAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HALLIBURTON CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HALLIBURTON CO's regulatory disclosures and financial reporting.
Capital Research Global Investors filed Amendment No. 3 to a Schedule 13G/A reporting beneficial ownership in Halliburton Co. The filing states CRGI is deemed beneficial owner of 56,355,626 shares, representing 6.7% of 837,548,345 shares believed to be outstanding. The filing lists sole voting power of 56,343,722 and sole dispositive power of 56,355,626.
Halliburton director Maurice S. Smith reported a compensation-related equity grant and updated his deferred and restricted stock holdings. On March 30, 2026, he received 827.815 stock equivalent units at a stated price of $0.00 under Halliburton’s Directors' Deferred Compensation Plan. These stock equivalent units convert into common stock on a one-for-one basis and are settled in company shares after his service as a director ends. A portion of the units reflects quarterly dividends and fees, based on closing prices of $38.63 and $39.26 in March 2026, and the plan is described as an ongoing securities acquisition program. Following this grant, Smith directly holds 13,768.454 stock equivalent units, in addition to several series of restricted stock units tied one-for-one to common shares, including 12/2025, 12/2024, 12/2023, and 03/2023 awards with underlying share amounts of 7,517.9400, 6,292.1000, 5,093.0800, and 4,070.4900, respectively. The restricted stock units vest over time, with the referenced award terms stating vesting after one year, and shares are delivered either upon vesting or, if he elected deferral, after his board service concludes.
Halliburton Company is asking shareholders to vote on twelve director nominees and several governance and compensation proposals at its May 20, 2026 annual meeting in Houston. The ballot includes ratifying KPMG as auditor, an advisory vote on executive pay, and charter and equity plan amendments.
In 2025, Halliburton generated $22.2 billion in revenue and produced strong free cash flow, returning $1.6 billion (nearly 85% of free cash flow) to shareholders via dividends and buybacks. Operating margins were 17% in Completion and Production and 15% in Drilling and Evaluation, with capital expenditures held near 6% of revenue.
The proxy outlines a pay program tying leadership incentives to Net Operating Profit After Taxes, asset turns, non‑financial strategic metrics, and three‑year Return on Capital Employed with a total shareholder return modifier. It also details active board refreshment, independence, committee oversight of sustainability, cybersecurity and AI, and extensive shareholder outreach representing about 61% of shares.
Halliburton Director, President & CEO Jeffrey Allen Miller sold 158,455 shares of common stock in an open-market sale at $40.0000 per share. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 13, 2025.
Following the sale, Miller directly owns 1,013,027.0200 shares of Halliburton common stock. He also holds vested options to buy 128,500 shares at an exercise price of $43.3800 expiring on December 6, 2027, and 69,500 shares at $53.5400 expiring on December 7, 2026.
HAL Form 144 filing reports a proposed sale by Jeffrey Miller of 171,200 shares on 01/23/2026 for $5,992,000.00.
The filing also lists several restricted stock vesting events with dated quantities: 90,975 (06/01/2022), 32,314 (12/02/2022), 20,249 (12/04/2022), and 14,917 (12/02/2023) as compensation-related issuances.
The Vanguard Group filed Amendment No. 12 on Schedule 13G/A reporting zero beneficial ownership of Halliburton Co common stock. The filing states 0 shares and 0% ownership following an internal realignment described under SEC Release No. 34-39538. The amendment is signed by Ashley Grim as Head of Global Fund Administration on 03/27/2026.
Halliburton Company executive Van H. Beckwith, EVP, Secretary and Chief Legal Officer, reported an open-market sale of 19,618 shares of common stock at $33.82 per share. After this transaction, he directly holds 344,535.49 shares. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025, indicating it was scheduled in advance rather than timed discretionarily.
Halliburton Company director and executive Jeffrey Shannon Slocum reported an open-market sale of 5,441 shares of Common Stock at a price of $33.82 per share. After this transaction, he directly holds 187,422.952 shares of Halliburton common stock.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 7, 2025. Slocum also continues to hold options to buy Halliburton common stock, including options with exercise prices of $49.61 and $55.68 per share that are exercisable for 12,090 and 3,722 underlying shares, respectively, with expiration dates in early 2028 and early 2027.
Van Beckwith submitted notices under Rule 144 to sell Common shares of HAL. The filing lists proposed sales linked to restricted stock vesting and prior sale activity, including 17,798 shares on 01/09/2026 and 54,348 shares on 01/23/2026.
HAL notice of proposed sale of 5,441 shares of Common Stock, linked to restricted stock vesting dated 02/27/2026. The Form 144 lists the securities as being offered for sale by the filer following vesting, with the filing information dated 03/16/2026.